Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Managing hereditary ovarian cancer risk.

Cancer - 1 Dec 1999

Berchuck A, Schildkraut J M, Marks J R, Futreal P A

Abstract excerpt

Ovarian cancer is the fourth leading cause of cancer deaths in American women. About 10% of cases are thought to have a hereditary basis, and family history is the strongest known risk factor. In the past, prophylactic oophorectomy has been advocated for women with two or more affected first-degr...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to BRCA2 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Neoplasm Proteins

Share to Ovarian Neoplasms

Share to Ovariectomy

Share to Transcription Factors

Source

Identifiers

PMID: 10630177
DOI: 10.1002/(sici)1097-0142(19991201)86:11+<2517::aid-cncr8>3.0.co;2-b

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-10630177-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Managing hereditary ovarian cancer risk.PMID 10630177Read ↗

Managing hereditary ovarian cancer.Semantic proximity Read ↗

Genetic susceptibility testing and prophylactic oophorectomy.Semantic proximity Read ↗

Managing hereditary breast cancer risk in women with and without ovarian cancer.Semantic proximity Read ↗

Identifying and managing hereditary risk of breast and ovarian cancer.Semantic proximity Read ↗

Hereditary ovarian cancer--assessing risk and prevention strategies.Semantic proximity Read ↗

Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal.Semantic proximity Read ↗

Retrospective evaluation of risk-reducing salpingo-oophorectomy for BRCA1/2 pathogenic variant carriers among a cohort study in a single institution.Semantic proximity Read ↗

Ovarian cancer: identifying and managing familial and genetic risk-summary of new NICE guidance.Semantic proximity Read ↗

Prevention of Ovarian Cancer: Where are We Now and Where are We Going?Semantic proximity Read ↗

Hereditary Ovarian Cancer and Risk Reduction.Semantic proximity Read ↗

Clinical management of patients at inherited risk for gynecologic cancer.Semantic proximity Read ↗

The potential for risk stratification in the management of ovarian cancer risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.